Tablets and Capsules Monday, September 06, 2010
Remove translation
 
DTR2010
Webinars
Subscribe Today for Free
Skip Navigation LinksHome) Webinar - Developing a Dissolution Test Method
Tablets & Capsules is the only technical publication devoted exclusively to readers in the tablet and capsule processing industries.
 

Developing a Dissolution Test Method Employing QbD


Date: Tuesday, February 23, 2010

Time: 12:00 PM (Noon) – 2:00 PM EDT

Program Highlights: Developing discriminating dissolution methods is paramount in the modern pharmaceutical laboratory and exemplifies the principles of Quality by Design (QbD).

This presentation will discuss how to develop dissolution methods that can predict the performance of drug products in vivo or in vitro. Learn ways to develop and challenge the dissolution method so that it is accurate and meaningful. Learn how to extend method development to encompass test conditions that are relevant to in vivo, that correlate to the drug-plasma data. Poorly soluble drugs and special dosage forms add another dimension to method development and will be explored, as will appropriate equipment. Since absorption of poorly soluble drugs is limited by the dissolution rate, drug products of this type (BCS Class 2: low solubility and high permeability) are good candidates for in vivo and in vitro correlation. A practical approach will be considered. The presentation also addresses how to set "clinically relevant specifications."

Led by Vivian Gray, the webinar comprises a 1-hour PowerPoint presentation, followed by another hour of questions and answers. Matthew Knopp, editor of Tablets & Capsules is the moderator.


To Register:

Webinar Cost: $99.00 USD

To Register: https://secure.netbriefings.com/event/tabletscapsules/Live/tc210/registercc.html

Visit our sponsor:
Copyright 2010, CSC Publishing Inc. ALL Rights Reserved * Privacy Policy